synthetic oligonucleotides
While the researchers have no plans to sell RNA chips based on the technology, they do intend to commercialize a device for synthesizing high-density arrays.
Twist Bioscience Reports 28 Percent Rise in Fiscal Q3 Revenues, Increases 2024 Guidance
The synthetic DNA maker reported record revenues of $81.5 million, beating the Wall Street estimate on the top line but missing on the bottom line.
Elegen Raises $35M in Series B Financing Round
In a statement, Elegen said it would use the funding to extend its production for clinical development of genetic medicines.
GSK, Elegen Ink Collaboration and Licensing Agreement for Synthetic DNA
GSK will provide Elegen with up to $35 million in near-term support and has made commitments to purchase synthetic DNA for use in developing genetic medicines.
The program is being launched with "redeployment" of existing funding at the Sanger Institute as well as supplemental funding from the Wellcome charitable foundation.